Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
CS

WKN: A2ALU7 | ISIN: US1266541028 | Ticker:
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
CV SCIENCES INC Chart 1 Jahr
5-Tage-Chart
CV SCIENCES INC 5-Tage-Chart

Aktuelle News zur CV SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrCV Sciences outlines multiple +PlusHLTH launches over next 12 to 24 months as Q3 gross margin reaches 50%2
12.11.CV Sciences, Inc. - 10-Q, Quarterly Report1
12.11.CV Sciences, Inc. Reports Third Quarter-End 2026 Financial Results323SAN DIEGO, CA / ACCESS Newswire / November 12, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...
► Artikel lesen
05.11.CV Sciences, Inc. To Announce Third Quarter 2026 Results On November 12, 2026382SAN DIEGO, CA / ACCESS Newswire / November 5, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
26.10.CV Sciences, Inc. - 8-K, Current Report2
08.09.CV Sciences, Inc.: CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework612Legislation delays implementation of new federal hemp restrictions until December 11, 2026, preserving continued access to naturally derived hemp products SAN DIEGO, CA / ACCESS Newswire / September...
► Artikel lesen
14.08.CV Sciences outlines hemp-rule delay to December 11, 2026 while expanding PlusHLTH.com and planning multiple 2026 launches1
CV SCIENCES Aktie jetzt für 0€ handeln
13.08.CV Sciences Q2 2026 Earnings Call Transcript1
13.08.CV Sciences, Inc. - 10-Q, Quarterly Report1
13.08.CV Sciences Non-GAAP EPS of $0.00, revenue of $2.99M1
13.08.CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results410SAN DIEGO, CA / ACCESS Newswire / August 13, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
12.08.CV Sciences, Inc.: CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids779New digital destination brings the Company's Health Intelligence approach to life, helping consumers better understand their needs, discover science-backed solutions, and navigate healthy aging. SAN...
► Artikel lesen
11.08.CV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026664SAN DIEGO, CA / ACCESS Newswire / August 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
26.06.CV Sciences, Inc.: CV Sciences Expands +PlusHLTH Portfolio with Personalized Wellness Solutions for Healthy Aging828Built on the Company's Health Intelligence Approach, the New Products Help Consumers Create Personalized Wellness Routines That Support Overall Health and Long-Term Vitality SAN DIEGO, CA / ACCESS Newswire...
► Artikel lesen
04.06.CV Sciences, Inc. - 8-K, Current Report2
14.05.CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results405SAN DIEGO, CA / ACCESS Newswire / May 14, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
13.05.CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026667SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
26.03.CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results698SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
24.03.CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026558SAN DIEGO, CA / ACCESS Newswire / March 24, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
10.03.CV Sciences, Inc.: CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth608SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven,...
► Artikel lesen
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1